|
1
|
Burdelya LG, Gleiberman AS, Toshkov I,
Aygun-Sunar S, Bapardekar M, Manderscheid-Kern P, Bellnier D,
Krivokrysenko VI, Feinstein E, Feinstein E and Gudkov AV: Toll-like
receptor 5 agonist protects mice from dermatitis and oral mucositis
caused by local radiation: Implications for head-and-neck cancer
radiotherapy. Int J Radiat Oncol Biol Phys. 83:228–234. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Imai T, Matsuura K, Asada Y, Sagai S,
Katagiri K, Ishida E, Saito D, Sadayasu R, Wada H and Saijo S:
Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in
head and neck cancer patients treated with concurrent
chemoradiotherapy. Jpn J Clin Oncol. 44:422–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Habl G, Potthoff K, Haefner MF, Abdollahi
A, Hassel JC, Boller E, Indorf M and Debus J: Differentiation of
irradiation and cetuximab induced skin reactions in patients with
locally advanced head and neck cancer undergoing
radioimmunotherapy: the HICARE protocol (head and neck cancer:
Immunochemo and radiotherapy with erbitux)-a multicenter phase IV
trial. BMC Cancer. 13:3452013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sonis ST: Oral mucositis. Anticancer
Drugs. 22:607–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyano K, Ueno T, Yatsuoka W and Uezono Y:
Treatment for Cancer Patients with Oral Mucositis: Assessment based
on the mucositis study group of the multinational association of
supportive care in cancer in international society of oral oncology
(MASCC/ISOO) in 2013 and proposal of possible novel treatment with
a Japanese herbal medicine. Curr Pharm Des. 22:2270–2278. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lalla RV, Sonis ST and Peterson DE:
Management of oral mucositis in patients who have cancer. Dent Clin
North Am. 52(61–77): viii2008.
|
|
7
|
Skubitz KM: Glutamine as a potential
treatment for the prevention of chemotherapy induced mucositis. J
Infusional Chemotherapy. 4:64–67. 1994.
|
|
8
|
Kyllo RL and Anadkat MJ: Dermatologic
adverse events to chemotherapeutic agents, part 1: Cytotoxics,
epidermal growth factor receptors, multikinase inhibitors, and
proteasome inhibitors. Semin Cutan Med Surg. 33:28–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shou J, Lieberman MD, Hofmann K, Leon P,
Redmond HP, Davies H and Daly JM: Dietary manipulation of
methotrexate-induced enterocolitis. J Parenter Enteral Nutr.
15:307–312. 1991. View Article : Google Scholar
|
|
10
|
Zhang M, Zhou J, Wang L, Li B, Guo J, Guan
X, Han Q and Zhang H: Caffeic acid reduces cutaneous tumor necrosis
factor alpha (TNF-α), IL-6 and IL-1β levels and ameliorates skin
edema in acute and chronic model of cutaneous inflammation in mice.
Biol Pharm Bull. 37:347–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu J, Luo C, Wang P, He Q, Zhou J and
Peng H: Saikosaponin A mediates the inflammatory response by
inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7
cells. Exp Ther Med. 5:1345–1350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McCarthy GM, Awde JD, Ghandi H, Vincent M
and Kocha WI: Risk factors associated with mucositis in cancer
patients receiving 5-fluorouracil. Oral Oncol. 34:484–490. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Keefe DM, Schubert MM, Elting LS, Sonis
ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB,
Hutchins RD and Peterson DE: Mucositis Study Section of the
Multinational Association of Supportive Care in Cancer and the
International Society for Oral Oncology: Updated clinical practice
guidelines for the prevention and treatment of mucositis. Cancer.
109:820–831. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peterson DE, Bensadoun RJ and Roila F:
ESMO Guidelines Working Group: Management of oral and
gastrointestinal mucositis: ESMO clinical recommendations. Ann
Oncol. 20 Suppl 4:S174–S177. 2009. View Article : Google Scholar
|
|
16
|
Quinn B, Potting CM, Stone R, Blijlevens
NM, Fliedner M, Margulies A and Sharp L: Guidelines for the
assessment of oral mucositis in adult chemotherapy, radiotherapy
and haematopoietic stem cell transplantation patients. Eur J
Cancer. 44:61–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henke M, Alfonsi M, Foa P, Giralt J,
Bardet E, Cerezo L, Salzwimmer M, Lizambri R, Emmerson L, Chen MG
and Berger D: Palifermin decreases severe oral mucositis of
patients undergoing postoperative radiochemotherapy for head and
neck cancer: A randomized, placebo-controlled trial. J Clin Oncol.
29:2815–2820. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bensinger W, Schubert M, Ang KK, Brizel D,
Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger
R, et al: NCCN Task Force Report. Prevention and management of
mucositis in cancer care. J Natl Compr Canc Netw. 6 Suppl 1:S1–S21;
quiz S22-S24. 2008.PubMed/NCBI
|
|
19
|
Svanberg A, Ohrn K and Birgegard G: Oral
cryotherapy reduces mucositis and improves nutrition-a randomised
controlled trial. J Clin Nurs. 19:2146–2151. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scully C, Epstein J and Sonis S: Oral
mucositis: A challenging complication of radiotherapy,
chemotherapy, and radiochemotherapy. Part 2: Diagnosis and
management of mucositis. Head Neck. 26:77–84. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cowen D, Tardieu C, Schubert M, Peterson
D, Resbeut M, Faucher C and Franquin JC: Low energy Helium-Neon
laser in the prevention of oral mucositis in patients undergoing
bone marrow transplant: Results of a double blind randomized trial.
Int J Radiat Oncol Biol Phys. 38:697–703. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Online EA Pharma Co., . Ltd Products
Information, Elental®. http://www.eapharma.co.jp/medicalexpert/product/elental/elental_information.htmlWebpage
in Japanese. 19–August. 2017
|
|
23
|
Yamamoto T, Nakahigashi M, Umegae S,
Kitagawa T and Matsumoto K: Impact of elemental diet on mucosal
inflammation in patients with active Crohn's disease: Cytokine
production and endoscopic and histological findings. Inflamm Bowel
Dis. 11:580–588. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanai H, Iida T, Takeuchi K, Arai H, Arai
O, Abe J, Tanaka T, Maruyama Y, Ikeya K, Sugimoto K, et al:
Nutritional therapy versus 6-mercaptopurine as maintenance therapy
in patients with Crohn's disease. Dig Liver Dis. 44:649–654. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Johtatsu T, Andoh A, Kurihara M, Iwakawa
H, Tsujikawa T, Kashiwagi A, Fujiyama Y and Sasaki M: Serum
concentrations of trace elements in patients with Crohn's disease
receiving enteral nutrition. J Clin Biochem Nutr. 41:197–201. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto T, Nakahigashi M, Saniabadi AR,
Iwata T, Maruyama Y, Umegae S and Matsumoto K: Impacts of long-term
enteral nutrition on clinical and endoscopic disease activities and
mucosal cytokines during remission in patients with Crohn's
disease: A prospective study. Inflamm Bowel Dis. 13:1493–1501.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamamoto T, Nakahigashi M, Umegae S,
Kitagawa T and Matsumoto K: Impact of long-term enteral nutrition
on clinical and endoscopic recurrence after resection for Crohn's
disease: A prospective, non-randomized, parallel, controlled study.
Aliment Pharmacol Ther. 25:67–72. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukui T, Itoh Y, Orihara M, Yoshizawa K,
Takeda H, Kawada S and Yoshioka T: Elental prevented and reduced
oral mucositis during chemotherapy in patients esophageal cancer.
Gan To Kagaku Ryoh. 38:2597–2601. 2011.(In Japanese).
|
|
29
|
Ogata Y, Takeuchi M, Ishibashi N, Kibe S,
Takahashi K, Uchida S, Murakami N, Yahara T and Shirouzu K:
Efficacy of Elental on prevention for chemotherapy-induced oral
mucositis in colorectal cancer patients. Gan To Kagaku Ryoho.
39:583–587. 2012.(In Japanese). PubMed/NCBI
|
|
30
|
Harada K, Ferdous T, Horinaga D, Uchida K,
Mano T, Mishima K, Park S, Hanazawa H, Takahashi S, Okita A, et al:
Efficacy of elemental diet on prevention for
chemoradiotherapy-induced oral mucositis in patients with oral
squamous cell carcinoma. Support Care Cancer. 24:953–959. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harada K, Ferdous T, Kobayashi H and
Ueyama Y: Elemental diet accelerates the recovery from oral
mucositis and dermatitis induced by 5-fluorouracil through the
induction of fibroblast growth factor 2. Integr Cancer Ther. July
1–2017.(Epub ahead of print). PubMed/NCBI
|
|
32
|
O'Dwyer ST, Scott T, Smith RJ and Wilmore
DW: 5-fluorouracil toxicity on small intestinal mucosa but not
white blood cells is decreased by glutamine. Clin Res.
35:367A1987.
|
|
33
|
Carneiro-Filho BA, Oriá RB, Rea Wood K,
Brito GA, Fujii J, Obrig T, Lima AA and Guerrant RL:
Alanyl-glutamine hastens morphologic recovery from
5-fluorouracil-induced mucositis in mice. Nutrition. 20:934–941.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kandil HM, Argenzio RA, Chen W,
Berschneider HM, Stiles AD, Westwick JK, Rippe RA, Brenner DA and
Rhoads JM: L-glutamine and l-asparagine stimulate ODC activity and
proliferation in a porcine jejunal enterocyte line. Am J physiol.
269:G591–G599. 1995.PubMed/NCBI
|
|
35
|
Rhoads JM, Argenzio RA, Chen W, Rippe RA,
Westwick JK, Cox AD, Berschneider HM and Brenner DA: L-glutamine
stimulates intestinal cell proliferation and activates
mitogen-activated protein kinases. Am J Physiol. 272:G943–G953.
1997.PubMed/NCBI
|
|
36
|
Hong RW, Rounds JD, Helton WS, Robinson MK
and Wilmore DW: Glutamine preserves liver glutathione after lethal
hepatic injury. Ann Surg. 215:114–119. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Denno R, Rounds JD, Faris R, Holejko LB
and Wilmore DW: Glutamine-enriched total parenteral nutrition
enhances plasma glutathione in the resting state. J Surg Res.
61:35–38. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou BR, Zhang JA, Zhang Q, Permatasari F,
Xu Y, Wu D, Yin ZQ and Luo D: Palmitic acid induces production of
proinflammatory cytokines interleukin-6, interleukin-1β, and tumor
necrosis factor-α via a NF-κB-dependent mechanism in HaCaT
keratinocytes. Mediators Inflamm. 2013:5304292013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baud V and Karin M: Is NF-kappaB a good
target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov.
8:33–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamamoto Y and Gaynor RB: Therapeutic
potential of inhibition of the NF-kappaB pathway in the treatment
of inflammation and cancer. J Clin Invest. 107:135–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
